Research / Stocks / MANH MANH Nasdaq CIK 0001056696
MANHATTAN ASSOCIATES INC · Services-Prepackaged Software
COVERAGE / STANDARD
Latest filing 4 · Aug 11, 2026
Research state Latest filing analysis is current
Last SEC check Sep 14, 2026
Data basis Official SEC · no quote feed Component status Filing Evidence Research Current Official SEC filing history is available
Structured Financials Research Current Validated structured financial research is available
Filing Analysis Research Current No filing analysis job is currently running
Fundamental State Research Current Fundamental State depends on validated comparable financial metrics
RESEARCH SNAPSHOT MANHATTAN ASSOCIATES INC's latest supported as-filed period reports revenue of $297.8M , 9.3% above the comparable as-filed period. Every value below links to its SEC accession and metric lineage.
Deterministic / evidence backed Key research observations No material rule-based research observation currently meets GrossPattern's Insight value threshold. Current state, direction, and filing evidence remain available below.
Current configuration / point in time Fundamental state A multidimensional view of the latest comparable filing—not a composite score or recommendation.
Capex intensity 0th Own-history percentile · N=8
Method Level · gp.fundamentals.capex_revenue_ratio
Raw value 0.34% · OPTIONAL
Operating cash generation 75th Own-history percentile · N=8
Method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
Raw value 30.45% · OPTIONAL
Revenue growth RAW Current state valid · history insufficient
Method Yoy · gp.fundamentals.revenue
Raw value 9.31% · CORE
Gross margin 75th Own-history percentile · N=8
Method Level · gp.fundamentals.gross_margin
Raw value 56.53% · CORE
Operating margin 0th Own-history percentile · N=8
Method Level · gp.fundamentals.operating_margin
Raw value 22.24% · CORE
R&D intensity 0th Own-history percentile · N=8
Method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
Raw value 11.67% · OPTIONAL
SBC intensity 63th Own-history percentile · N=8
Method Level · gp.fundamentals.sbc_revenue_ratio
Raw value 9.86% · OPTIONAL
Deterministic multi-period research Company direction Business direction, financial quality, capital allocation, and governance evidence remain separate—never collapsed into a recommendation score.
As filed Jun 30, 2026 General Corporate
Capital Allocation 4 evidence-backed dimensions Capex Intensity Inflecting Cash Generation Improving R And D Intensity Decreasing Sbc Intensity Inflecting [email protected] · 9 historical states · 38% confidenceCompany Direction 7 evidence-backed dimensions Capex Intensity Inflecting Cash Generation Improving Margin Stable Profitability Inflecting R And D Intensity Decreasing [email protected] · 9 historical states · 36% confidenceFinancial Quality 4 evidence-backed dimensions Cash Generation Improving Margin Stable Profitability Inflecting Sbc Intensity Inflecting [email protected] · 9 historical states · 38% confidenceGovernance Evidence 4 evidence-backed dimensions Filing Amendments Observed Auditor Changes None Detected Sbc Intensity Observed Insider Activity Observed [email protected] · 9 historical states · 50% confidenceInterpretation boundary Direction describes measurable company fundamentals. Governance reports observable evidence only; it does not grade management character or predict stock returns.
Comparable evidence Peer context Latest available comparable states within 180 days, normalized with robust median/MAD statistics.
Margin
MANH 56.5
Peer median 72.6
Peer percentile 21th 131 valid peers · 83% coverage · -1.2 robust σ Profitability
MANH 22.2
Peer median -1.8
Peer percentile 89th 148 valid peers · 94% coverage · +1.1 robust σ R And D Intensity
MANH 11.7
Peer median 21.6
Peer percentile 15th 131 valid peers · 83% coverage · -0.8 robust σ Cash Generation
MANH 30.5
Peer median 16.4
Peer percentile 80th 143 valid peers · 91% coverage · +0.7 robust σ Capex Intensity
MANH 0.3
Peer median 1.0
Peer percentile 23th 124 valid peers · 79% coverage · -0.5 robust σ Sbc Intensity
MANH 9.9
Peer median 10.9
Peer percentile 46th 142 valid peers · 90% coverage · -0.1 robust σ Open group breadth → Divergence is context, not positive or negative. INSIDER STATE / 90D Recent disclosed activity
Open-market purchases 0
Sales 0
Distinct buyers 0
Repeat buyer NO Conservative Form 4 classification · not a sentiment label Flagship analysis / V3 What changed? The most important deterministic changes, ranked by magnitude, issuer history, persistence, and accounting profile.
Current 10-Q 0001193125-26-327591 6 governed changes · top 6 shown
01
HIGH IMPORTANCE Cash 75TH HISTORICAL PCTL · N=4
Cash & equivalents decreased 19.3% Cash & equivalents changed -19.3% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Why this ranks here · [email protected] $230.6M → $186.1M Comparable → current
02
LOW IMPORTANCE Net Income 67TH HISTORICAL PCTL · N=3
Net income decreased 11.3% Net income changed -11.3% from the comparable as-filed period.
Why this ranks here · [email protected] $56.8M → $50.4M Comparable → current
03
LOW IMPORTANCE Operating Income 67TH HISTORICAL PCTL · N=3
Operating income decreased 10.2% Operating income changed -10.2% from the comparable as-filed period.
Why this ranks here · [email protected] $73.8M → $66.2M Comparable → current
04
HIGH IMPORTANCE Margin 100TH HISTORICAL PCTL · N=3
Operating margin moved 485 bp lower As-filed financials Financial trajectory Each point keeps the date investors could first observe it and its accession.
As filed Current normalized · later
Capex / revenue 0.34% -76.8% ↓ Capital expenditure $1.0M -75.5% ↓ Cash & equivalents $186.1M +0.0% ↑ Free-cash-flow proxy $89.7M +12.2% ↑ Gross margin 56.53% +2.5% ↑ Net income $50.4M +2.1% ↑ Operating cash flow $90.7M +7.9% ↑ Operating margin 22.24% +0.0% ↑
ACTIVE TRACE Revenue MANH · as filed with the SEC · reported-date aware
Capex / revenue Q2 / 2026-06-30 0.34% -76.8% sequential point Trace ↗ Evidence inspector
Loading lineage… × Capital expenditure Q2 / 2026-06-30 $1.0M -75.5% sequential point Trace ↗ Evidence inspector
Loading lineage… × Cash & equivalents Q2 / 2026-06-30 $186.1M +0.0% sequential point Trace ↗ Evidence inspector
Loading lineage… × Free-cash-flow proxy Q2 / 2026-06-30 $89.7M +12.2% sequential point Trace ↗ Evidence inspector
Loading lineage… × Gross margin Q2 / 2026-06-30 56.53% +2.5% sequential point Trace ↗ Evidence inspector
Loading lineage… × Net income Q2 / 2026-06-30 $50.4M +2.1% sequential point Trace ↗ Evidence inspector
Loading lineage… × Operating cash flow Q2 / 2026-06-30 $90.7M +7.9% sequential point Trace ↗ Evidence inspector
Loading lineage… × Operating margin Q2 / 2026-06-30 22.24% +0.0% sequential point Trace ↗ Evidence inspector
Loading lineage… × Research & development Q2 / 2026-06-30 $34.8M -6.9% sequential point Trace ↗ Evidence inspector
Loading lineage… × Revenue Q2 / 2026-06-30 $297.8M +5.5% sequential point Trace ↗ Evidence inspector
Loading lineage… × Stock-based compensation Q2 / 2026-06-30 $29.4M +10.7% sequential point Trace ↗ Evidence inspector
Loading lineage… × Primary evidence Filing timeline Direct SEC links, filing dates, report periods, and amendment flags.
4 Aug 11, 2026 Period Aug 11, 2026 0001225208-26-007068SEC ↗ 4 Aug 10, 2026 Period Aug 6, 2026 0001225208-26-007043SEC ↗ 4 Jul 31, 2026 Period Jul 30, 2026 0001225208-26-006859SEC ↗ 10-Q Jul 31, 2026 Period Jun 30, 2026 0001193125-26-327591SEC ↗ 8-K Jul 28, 2026 Period Jul 28, 2026 0001193125-26-320952SEC ↗ 4 Jun 16, 2026 Period Jun 15, 2026 0001225208-26-006059SEC ↗ 4 Jun 10, 2026 Period Jun 10, 2026 0001225208-26-005910SEC ↗ Form 4 Insider activity Transaction semantics distinguish purchases, sales, awards, exercises, withholding, and derivatives.
“Insider purchase” rule Code P · non-derivative · acquired · direct ownership · positive price and shares · not amended
Inspectable by design
Every displayed number has a lineage. GrossPattern stores immutable raw artifacts, accession-scoped facts, parser and metric versions, dependency edges, quality state, and channel-specific publication rights. A restricted or unknown ancestor blocks the page and API automatically.
SEC source policy ↗